This review aims to summarize evidence on the association between TNF-α and adiponectin with NAFLD-associated HCC, based on experimental and clinical studies, and to discuss relevant potential therapeutic considerations. This evidence concerns the gene TNF and metabolic dysfunction-associated steatotic liver disease.